
Cardiac Safety Services Market Report 2026
Global Outlook – By Services (ECG Or Holter Measurements, Blood Pressure Measurements, In Vitro Cardiac Safety Assessment Services, Cardiovascular Imaging, Real-Time Telemetry Monitoring, Central Over-Read Of ECGS, Non-Invasive Cardiac Imaging, Physiologic Stress Testing, Thorough QT Studies), By Phase (Phase 1, Phase 2, Phase 3), By End User (Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institute) - Market Size, Trends, And Global Forecast 2026-2035
Cardiac Safety Services Market Overview
• Cardiac Safety Services market size has reached to $1.16 billion in 2025 • Expected to grow to $1.94 billion in 2030 at a compound annual growth rate (CAGR) of 10.7% • Growth Driver: Rising Aging Population Drives Growth In Cardiac Safety Services Market • Market Trend: AI And ML-Powered Tools For Enhanced Assessments In Cardiac Safety Services Market • North America was the largest region in 2025.What Is Covered Under Cardiac Safety Services Market?
Cardiac safety services refer to offering services related to monitoring heart safety by giving the required support and help in designing clinical trials and other research. Cardiac safety services typically help with planning clinical trials and other investigations necessary to maintain cardiac safety. The main services of cardiac safety services are ECG or Holter measurements, blood pressure measurements, in vitro cardiac safety assessment services, cardiovascular imaging, real-time telemetry monitoring, central over-read of ECGs, non-invasive cardiac imaging, physiologic stress testing, thorough qt studies, and others. The Holter measurement is a type of portable electrocardiogram (ECG) that records the electrical activity of the heart continuously over 24 hours or longer when the patient is away from the doctor. The phases involved are Phase 1, phase 2, and phase 3 which are used by pharmaceutical and biopharmaceutical companies, contract research organizations and academic and research institute.
What Is The Cardiac Safety Services Market Size and Share 2026?
The cardiac safety services market size has grown rapidly in recent years. It will grow from $1.16 billion in 2025 to $1.29 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing complexity of clinical trial protocols, rising regulatory scrutiny on cardiac safety, growth in early-phase drug development activity, increased incidence of drug-induced cardiotoxicity concerns, expansion of outsourcing to specialized service providers.What Is The Cardiac Safety Services Market Growth Forecast?
The cardiac safety services market size is expected to see rapid growth in the next few years. It will grow to $1.94 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing demand for integrated cardiac safety platforms, rising adoption of remote monitoring technologies, expansion of decentralized clinical trials, growing focus on predictive cardiac safety analytics, increasing investment in advanced cardiac biomarkers. Major trends in the forecast period include increasing adoption of centralized ecg monitoring services, rising demand for real-time telemetry in clinical trials, growing use of advanced cardiac imaging in drug safety, expansion of thorough qt study requirements, enhanced focus on early-phase cardiac risk assessment.Global Cardiac Safety Services Market Segmentation
1) By Services: ECG Or Holter Measurements, Blood Pressure Measurements, In Vitro Cardiac Safety Assessment Services, Cardiovascular Imaging, Real-Time Telemetry Monitoring, Central Over-Read Of ECGS, Non-Invasive Cardiac Imaging, Physiologic Stress Testing, Thorough QT Studies 2) By Phase: Phase 1, Phase 2, Phase 3 3) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institute Subsegments: 1) By ECG Or Holter Measurements: Standard ECG Monitoring, 24-Hour Holter Monitoring, Event Monitoring 2) By Blood Pressure Measurements: Continuous Blood Pressure Monitoring, Ambulatory Blood Pressure Monitoring, In-Hospital Blood Pressure Measurements 3) By In Vitro Cardiac Safety Assessment Services: Cardiomyocyte Toxicity Testing, Cardiac Ion Channel Testing, Mechanistic Studies 4) By Cardiovascular Imaging: Echocardiography, MRI Imaging, CT Angiography 5) By Real-Time Telemetry Monitoring: Remote Patient Monitoring, Continuous Telemetry Services 6) By Central Over-Read Of ECGs: ECG Interpretation Services, Quality Control And Reporting 7) By Non-Invasive Cardiac Imaging: Stress Testing, Nuclear Cardiology 8) By Physiologic Stress Testing: Exercise Stress Testing, Pharmacologic Stress Testing 9) By Thorough QT Studies: Clinical Trial Services, Safety Assessments For Drug DevelopmentWhat Is The Driver Of The Cardiac Safety Services Market?
The growing aging population is expected to propel the growth of the cardiac safety services market going forward. Aging population refers to the increasing median age in a population due to declining fertility rates and rising life expectancy. As the population ages, the incidence of cardiovascular diseases increases, leading to a higher demand for cardiac safety services. The aging population requires specialized care and management for geriatric syndromes in cardiac intensive care units, which can benefit from cardiac safety services. For instance, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization, the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. This age group’s share of the overall population is also projected to rise from 17% to 23% during the same period. Therefore, the growing aging population is driving the growth of the cardiac safety services industry.Key Players In The Global Cardiac Safety Services Market
Major companies operating in the cardiac safety services market are Laboratory Corporation of America Holdings, Banook Group Limited, Pharmaceutical Product Development LLC, Biotrial S.A., Certara Inc., Celerion Inc., Medpace Holdings Inc., Ncardia AG, Richmond Pharmacology Limited, SGS Société Générale de Surveillance SA, Clario, Eurofins Scientific SE, Spaulding Clinical Research LLC, ERT Inc., IQVIA Holdings Inc., Bioclinica Inc., ICON plc, BioTelemetry Inc., PPD Inc., Parexel International Corporation, Chiltern International Limited, Biomedical Systems, High Point Clinical Trials Center, Maastricht University Medical Centre+, CCBR-SYNARC, Medicalgorithmics S.A., Advarra Inc.Global Cardiac Safety Services Market Trends and Insights
Major companies operating in the cardiac safety services market are integrating their efforts into launching next-gen solutions, such as AI and ML-powered cardiac safety tools, to gain a competitive edge in the market. These tools use ECG data to provide detailed information on the acquired continuous ECG data, including whether it is of high quality or not. The AI and ML algorithms are trained on large datasets of ECG data to provide accurate and reliable results. For instance, in November 2023, Clario, a US-based healthcare company, launched its new AI-powered ECG quality score tool to enhance cardiac safety assessments. It uses a unique form of machine learning and artificial intelligence to improve the quality of cardiac safety data. Sponsors can take advantage of this actionable intelligence to provide proactive corrections and peace of mind regarding data quality. An artificial intelligence (AI) tool enhances Clario's market-leading Early Precision QT (EPQT) early phase solution, which may allow for the waiver of conventional Thorough QT (TQT) investigations.What Are Latest Mergers And Acquisitions In The Cardiac Safety Services Market?
In October 2023, Motion Equity Partners, a France-based private equity company, acquired Banook Group for an undisclosed amount. With this acquisition, Motion Equity Partners aims to enhance Banook Group's growth potential and expand its market reach, leveraging the firm's expertise and resources to drive innovation and operational efficiencies within the company. Banook Group is a France-based technology company specializing in digital solutions and services for the media and telecommunications sectors.Regional Outlook
North America was the largest region in the cardiac safety services market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Cardiac Safety Services Market?
The cardiac safety services market includes revenues earned by companies by providing cardiac safety monitoring, ventricular arrhythmias, and cardiovascular performance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Cardiac Safety Services Market Report 2026?
The cardiac safety services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac safety services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Cardiac Safety Services Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.29 billion |
| Revenue Forecast In 2035 | $1.94 billion |
| Growth Rate | CAGR of 10.6% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Services, Phase, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Laboratory Corporation of America Holdings, Banook Group Limited, Pharmaceutical Product Development LLC, Biotrial S.A., Certara Inc., Celerion Inc., Medpace Holdings Inc., Ncardia AG, Richmond Pharmacology Limited, SGS Société Générale de Surveillance SA, Clario, Eurofins Scientific SE, Spaulding Clinical Research LLC, ERT Inc., IQVIA Holdings Inc., Bioclinica Inc., ICON plc, BioTelemetry Inc., PPD Inc., Parexel International Corporation, Chiltern International Limited, Biomedical Systems, High Point Clinical Trials Center, Maastricht University Medical Centre+, CCBR-SYNARC, Medicalgorithmics S.A., Advarra Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
